{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:46:19Z","timestamp":1772689579281,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T00:00:00Z","timestamp":1551571200000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"CTSA","award":["UL1 TR000142"],"award-info":[{"award-number":["UL1 TR000142"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jclinepi.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:47:49Z","timestamp":1518158869000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A joint frailty model provides for risk stratification of human immunodeficiency virus\u2013infected patients based on unobserved heterogeneity"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-3420","authenticated-orcid":false,"given":"Tae Hyun","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tassos","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-7982","authenticated-orcid":false,"given":"Mark","family":"Holodniy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Peduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2018.02.007_bib1","series-title":"AIDS by the numbers","year":"2016"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib2","series-title":"Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents","first-page":"1","year":"2016"},{"issue":"1","key":"10.1016\/j.jclinepi.2018.02.007_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ejhf.29","article-title":"Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved","volume":"16","author":"Rogers","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/sim.4780141903","article-title":"The design and analysis of randomized trials with recurrent events","volume":"14","author":"Cook","year":"1995","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5","article-title":"Survival analysis for recurrent event data: an application to childhood infectious diseases","volume":"19","author":"Kelly","year":"2000","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.jclinepi.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1532-5415.2010.02767.x","article-title":"Competing risk of death: an important consideration in studies of older adults","volume":"58","author":"Berry","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.jclinepi.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCOUTCOMES.115.001841","article-title":"Semi-competing risks data analysis: accounting for death as a competing risk when the outcome of interest is nonterminal","volume":"9","author":"Haneuse","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.0006-341X.2004.00225.x","article-title":"Shared frailty models for recurrent events and a terminal event","volume":"60","author":"Liu","year":"2004","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.jclinepi.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/biostatistics\/kxl043","article-title":"Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events","volume":"8","author":"Rondeau","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/sim.6140","article-title":"A joint frailty model to estimate the recurrence process and the disease-specific mortality process without needing the cause of death","volume":"33","author":"Belot","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib12","first-page":"603","volume":"Vol. 23","author":"Cai","year":"2003"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib13","series-title":"Statistics for Biology and Health","article-title":"The Statistical Analysis of Recurrent Events","author":"Cook","year":"2007"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"e14764","DOI":"10.1371\/journal.pone.0014764","article-title":"Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial","volume":"6","author":"Holodniy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0197-2456(03)00029-1","article-title":"An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial","volume":"24","author":"Kyriakides","year":"2003","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1191\/1740774504cn022oa","article-title":"Study conduct, monitoring and data management in a trinational trial: the OPTIMA model","volume":"1","author":"Kyriakides","year":"2004","journal-title":"Clin Trials"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/clinids\/17.4.802","article-title":"1993 revised classification-system for HIV-infection and expanded surveillance case-definition for AIDS among adolescents and adults (Reprinted from MMWR, Vol 41, Pg Rr 17, 1992)","volume":"17","author":"Castro","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib18","series-title":"Modeling survival data: extending the Cox model. Statistics for biology and health","author":"Therneau","year":"2001"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAI.0b013e31827df36c","article-title":"Predictive accuracy of the Veterans aging cohort study index for mortality with HIV infection; a North American cross cohort analysis","volume":"62","author":"Justice","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e32835b8c7f","article-title":"An internationally generalizable risk index after one year of antiretroviral therapy","volume":"27","author":"Tate","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.jclinepi.2018.02.007_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0258(20000530)19:10<1303::AID-SIM424>3.0.CO;2-E","article-title":"A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations","volume":"19","author":"Lin","year":"2000","journal-title":"Stat Med"},{"issue":"457","key":"10.1016\/j.jclinepi.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1198\/016214502753479220","article-title":"Latent class models for joint analysis of longitudinal biomarker and event process data: application to longitudinal prostate-specific antigen readings and prostate cancer","volume":"97","author":"Lin","year":"2002","journal-title":"J Am Stat Assoc"},{"issue":"406","key":"10.1016\/j.jclinepi.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/01621459.1989.10478795","article-title":"Bivariate survival models induced by frailties","volume":"84","author":"Oakes","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"3","key":"10.1016\/j.jclinepi.2018.02.007_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00128978","article-title":"Bivariate frailty model for the analysis of multivariate survival time","volume":"2","author":"Xue","year":"1996","journal-title":"Lifetime Data Anal"},{"issue":"1","key":"10.1016\/j.jclinepi.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/biostatistics\/5.1.129","article-title":"Tests for multivariate recurrent events in the presence of a terminal event","volume":"5","author":"Chen","year":"2004","journal-title":"Biostatistics"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617306248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435617306248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:14:45Z","timestamp":1760246085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435617306248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"alternative-id":["S0895435617306248"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.02.007","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A joint frailty model provides for risk stratification of human immunodeficiency virus\u2013infected patients based on unobserved heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}